Related references
Note: Only part of the references are listed.On the (not so) constant proportional trade-off in TTO
Arthur E. Attema et al.
QUALITY OF LIFE RESEARCH (2010)
Quality of life after a subtrochanteric fracture A prospective cohort study on 87 elderly patients
Wilhelmina Ekstrom et al.
INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED (2009)
Quality of Life After a Stable Trochanteric Fracture-A Prospective Cohort Study on 148 Patients
Wilhelmina Ekstrom et al.
JOURNAL OF ORTHOPAEDIC TRAUMA (2009)
Relative Efficiency of the EQ-5D, HUI2, and HUI3 Index Scores in Measuring Health Burden of Chronic Medical Conditions in a Population Health Survey in the United States
Nan Luo et al.
MEDICAL CARE (2009)
Methods for Measuring Temporary Health States for Cost-Utility Analyses
Davene R. Wright et al.
PHARMACOECONOMICS (2009)
Migraine frequency and health utilities: Findings from a multisite survey
Jeffrey S. Brown et al.
VALUE IN HEALTH (2008)
Randomized controlled trial of an oral CGRP receptor antagonist, MK-0974, in acute treatment of migraine
T. W. Ho et al.
NEUROLOGY (2008)
The migraine cycle: Patient burden of migraine during and between migraine attacks
Jan Lewis Brandes
HEADACHE (2008)
Health-related quality of life in women with symptomatic hand osteoarthritis: A comparison with rheumatoid arthritis patients, healthy controls, and normative data
Barbara Slatkowsky-Christensen et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2007)
Cessation versus continuation of 6-month migraine preventive therapy with topiramate (PROMPT): a randomised, double-blind, placebo-controlled trial
Hans-Christoph Diener et al.
LANCET NEUROLOGY (2007)
The impact of topiramate on health-related quality of life indicators in chronic migraine
David W. Dodick et al.
HEADACHE (2007)
The impact of migraine prevention on daily activities:: a longitudinal and responder analysis from three topiramate placebo-controlled clinical trials
Carl Dahlof et al.
HEALTH AND QUALITY OF LIFE OUTCOMES (2007)
A case-control study on excessive daytime sleepiness in episodic migraine
P. Barbanti et al.
CEPHALALGIA (2007)
On the assessment of preferences for health and duration - Maximal endurable time and better than dead preferences
Peep F. M. Stalmeier et al.
MEDICAL CARE (2007)
Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study
H-C Diener et al.
CEPHALALGIA (2007)
Psychometric comparison of the standard EQ-5D to a 5 level version in cancer patients
A. Simon Pickard et al.
MEDICAL CARE (2007)
The impact of 29 chronic conditions on health-related quality of life:: A general population survey in finland using 15D and EQ-5D
Samuli I. Saarni et al.
QUALITY OF LIFE RESEARCH (2006)
Self-reported chronic conditions and EQ-5D index scores in the US adult population
Yu Ko et al.
CURRENT MEDICAL RESEARCH AND OPINION (2006)
Migraine: a review and future directions for treatment
M. Linde
ACTA NEUROLOGICA SCANDINAVICA (2006)
Preference-based EQ-5D index scores for chronic conditions in the United States
Patrick W. Sullivan et al.
MEDICAL DECISION MAKING (2006)
US valuation of the EQ-5D health states - Development and testing of the D1 valuation model
JW Shaw et al.
MEDICAL CARE (2005)
Valuations of EQ-5D health states - Are the United States and United kingdom different?
JA Johnson et al.
MEDICAL CARE (2005)
Topiramate improves health-related quality of life when used to prevent migraine
M Diamond et al.
HEADACHE (2005)
Interictal daily functioning in migraine
DL Stronks et al.
CEPHALALGIA (2004)
Prophylactic treatment of migraine with an angiotensin II receptor blocker - A randomized controlled trial
E Tronvik et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
A comparison of visual analog scale and categorical ratings of headache pain in a randomized controlled clinical trial with migraine patients
CR Lines et al.
PAIN (2001)
Migraine diagnosis and treatment: Results from the American Migraine Study II
RB Lipton et al.
HEADACHE (2001)
Prevalence and burden of migraine in the United States: Data from the American Migraine Study II
RB Lipton et al.
HEADACHE (2001)
Can the Health Utilities Index measure change?
JA Kopec et al.
MEDICAL CARE (2001)
Prophylactic treatment of migraine with angiotensin converting enzyme inhibitor (lisinopril): randomised, placebo controlled, crossover study
H Schrader et al.
BMJ-BRITISH MEDICAL JOURNAL (2001)
Share Paper
